Department of Gastroenterology, Chuno Kosei Hospital, 5-1 Wakusadori, Seki, Gifu, 501-3802, Japan.
Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.
Clin J Gastroenterol. 2020 Oct;13(5):882-890. doi: 10.1007/s12328-020-01142-3. Epub 2020 May 29.
Spur cell anemia is an acquired hemolytic anemia associated with liver cirrhosis and is characterized by the presence of increased large red blood cells, which are covered with spike-like projections that vary in width, length, and distribution. A 26-year-old man was referred to our hospital presenting with jaundice, lower limb edema, and dyspnea. The patient was subsequently diagnosed with spur cell anemia related to alcoholic liver cirrhosis. Spur cell anemia is an independent predictor of mortality in liver cirrhosis and has been associated with extremely poor prognosis. The most effective treatment for spur cell anemia is liver transplantation. As seen in the literature, the treatment of spur cell anemia without liver transplantation is quite challenging. This report highlights the importance of management and treatment strategies, including control of fluid retention, blood transfusion, plasma diafiltration, and administration of diuretics. Our treatment strategies might be useful in patients who are not candidate of liver transplantation or patients waiting for liver transplantation.
棘状红细胞贫血是一种获得性溶血性贫血,与肝硬化相关,其特征是存在大量红细胞增多,这些红细胞表面覆盖着宽窄、长短和分布不一的刺状突起。一名 26 岁男性因黄疸、下肢水肿和呼吸困难就诊于我院。该患者随后被诊断为酒精性肝硬化相关的棘状红细胞贫血。棘状红细胞贫血是肝硬化患者死亡的独立预测因子,与极差的预后相关。棘状红细胞贫血的最有效治疗方法是肝移植。文献报道,未经肝移植治疗的棘状红细胞贫血极具挑战性。本报告强调了管理和治疗策略的重要性,包括控制液体潴留、输血、血浆超滤和利尿剂的应用。我们的治疗策略可能对不适合肝移植或等待肝移植的患者有用。